P2Y12-based platelet function assays should be complemented with cyclooxygenase-dependent testing in framing the therapeutic windows for dual antiplatelet therapy

JACC Cardiovasc Interv. 2014 Jan;7(1):107-8. doi: 10.1016/j.jcin.2013.09.005.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Acute Coronary Syndrome / therapy*
  • Female
  • Hemorrhage / chemically induced*
  • Humans
  • Male
  • Percutaneous Coronary Intervention*
  • Piperazines / adverse effects*
  • Platelet Activation / drug effects*
  • Platelet Aggregation Inhibitors / adverse effects*
  • Thiophenes / adverse effects*
  • Ticlopidine / analogs & derivatives*

Substances

  • Piperazines
  • Platelet Aggregation Inhibitors
  • Thiophenes
  • Ticlopidine